Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Other Accumulated Expenses (2020 - 2025)

GoHealth's Other Accumulated Expenses history spans 6 years, with the latest figure at $3.7 million for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses fell 83.89% year-over-year to $3.7 million; the TTM value through Sep 2025 reached $3.7 million, down 83.89%, while the annual FY2024 figure was $4.4 million, 20.93% down from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $3.7 million at GoHealth, up from $3.7 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $23.1 million in Q3 2024 and bottomed at $3.7 million in Q2 2025.
  • The 5-year median for Other Accumulated Expenses is $10.8 million (2021), against an average of $10.6 million.
  • The largest annual shift saw Other Accumulated Expenses surged 777.82% in 2021 before it crashed 83.89% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $8.3 million in 2021, then increased by 21.19% to $10.1 million in 2022, then plummeted by 44.73% to $5.6 million in 2023, then dropped by 20.93% to $4.4 million in 2024, then decreased by 15.89% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Other Accumulated Expenses are $3.7 million (Q3 2025), $3.7 million (Q2 2025), and $4.1 million (Q1 2025).